Zimmer Receives Pediatric Clearance for Universal Clamp Spinal Fixation System

WARSAW, Ind., Sept. 14, 2011 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH;
SIX: ZMH) announced today that it has received an additional clearance for its
proprietary Universal Clamp Spinal Fixation System. A first for the United
States, the system is now indicated for treatment of idiopathic and
neuromuscular scoliosis in patients eight years of age or older. The Universal
Clamp Spinal Fixation System is used in conjunction with spinal fusion
surgeries.

Scoliosis is a debilitating condition characterized by spine curvature and back
pain. In the United States, scoliosis affects approximately two to three percent
of the population with more than 27,000 cases a year determined to be serious
enough to require surgery. Scoliosis is commonly diagnosed in childhood and
early adolescence, with between three and five of every 1,000 children
developing spinal curves that are considered large enough for treatment. The
most common surgical intervention performed to correct severe scoliosis is
spinal fusion.

Zimmer’s Universal Clamp System was designed for use in conjunction with spinal
deformity procedures. Introduced in Europe in 2006 and in the United States in
2008, the Universal Clamp Implant offers a pedicle-sparing approach for
malformed or small thoracic pedicles while still providing similar stability to
pedicle screw constructs. The Universal Clamp band spreads contact forces over a
greater surface area, thereby reducing the risk of pulling through the lamina
compared to wires and hooks. The system’s reduction instrumentation allows
surgeons to sequentially reduce deformity and spread the reduction forces over
multiple levels.

“Scoliosis affects a significant number of young patients in the United States
each year,” said Steve Healy, President of Zimmer Spine. “We are excited to make
the Universal Clamp System available as an advanced solution for surgeons
treating young patients.”

Since its introduction, the Universal Clamp System has been successfully used in
more than 24,000 procedures worldwide. Following the latest clearance, Zimmer
can now provide training and education for surgeons to treat child and
adolescent patients in the United States with the technology.

For more information on Zimmer Spine and the Universal Clamp Spinal Fixation
System, visit www.zimmer.com.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops,
manufactures and markets orthopaedic reconstructive, spinal and trauma devices,
dental implants, and related surgical products. Zimmer has operations in more
than 25 countries around the world and sells products in more than 100
countries. Zimmer’s 2010 sales were approximately $4.2 billion. The Company is
supported by the efforts of more than 8,000 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management’s beliefs and assumptions made by management.
Forward-looking statements may be identified by the use of forward-looking terms
such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,”
“estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and
“seeks” or the negative of such terms or other variations on such terms or
comparable terminology. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that could cause
actual outcomes and results to differ materially. For a list and description of
such risks and uncertainties, see our periodic reports filed with the U.S.
Securities and Exchange Commission. We disclaim any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be set forth in our
periodic reports. Readers of this document are cautioned not to place undue
reliance on these forward-looking statements, since, while we believe the
assumptions on which the forward-looking statements are based are reasonable,
there can be no assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all forward-looking
statements contained in this document.